Activation of PKC-δ plays an important regulatory role in myocardial ischemia/reperfusion (IRI) injury and myocardial fibrosis, and is involved in many cardiovascular diseases, such as atherosclerosis, hypertension, myocardial hypertrophy, and heart failure. Here, PRKCD is linked to heart failure.